Increased accuracy and confidence to better evaluate market opportunities and allocation of investments
Speak to our teamResearch teams need to obtain faster and more timely answers to their business questions.
Because of evolving market dynamics, it is increasingly essential that pharmas get their forecasting right, whether for a broad therapy area or a sub-population of patients. However, most research methods have limitations that can result in inaccurate forecasts — with costly repercussions.
Our data scientists and epidemiologists combine epidemiology with real world data, helping pharma teams gain a deep understanding of a disease population for more accurate forecasting and greater confidence in planning commercial investments.
Clarivate combines epidemiology and real world data so research teams can:
Benchmark your forecasts with data on the total potential and addressable market
Validate your investments using bottom-up forecasting
Identify growth opportunities and understand how populations will change over time
Track disease stages, sub-populations and treatment flow
Estimate drug-treated populations with insights from therapeutic experts and primary market research
We partner with brand teams to answer tough business questions, laying the groundwork for precise forecasting and strategic implementation:
Segment by therapy area
Segment by sub-population
Key questions:
By fusing multiple data sources, true market opportunity is revealed, sales force teams are optimized, and commercial effectiveness is enabled:
Claims
Electronic health records
Epidemiology
Health plan formulary & lives
Social data
Healthcare provider affiliation directory
Contact us to connect with a specialist on how we can support your market sizing needs
